![Novel pulsatile cerebrospinal fluid model to assess pressure manometry and fluid sampling through spinal needles of different gauge: support for the use of a 22 G spinal needle with a tapered 27 Novel pulsatile cerebrospinal fluid model to assess pressure manometry and fluid sampling through spinal needles of different gauge: support for the use of a 22 G spinal needle with a tapered 27](https://www.bjanaesthesia.org.uk/cms/attachment/b053472b-0fd0-4909-b5f0-b229a03d5335/gr1.jpg)
Novel pulsatile cerebrospinal fluid model to assess pressure manometry and fluid sampling through spinal needles of different gauge: support for the use of a 22 G spinal needle with a tapered 27
![Five-Year Survival Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Metastatic Non–Small-Cell Lung Cancer in CheckMate 227 | Journal of Clinical Oncology Five-Year Survival Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Metastatic Non–Small-Cell Lung Cancer in CheckMate 227 | Journal of Clinical Oncology](https://ascopubs.org/cms/10.1200/JCO.2023.41.issue-6/asset/1868422c-b518-8422-9b51-68422c9b5186/jco.2023.41.issue-6.cover.gif)
Five-Year Survival Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Metastatic Non–Small-Cell Lung Cancer in CheckMate 227 | Journal of Clinical Oncology
![The Life of Pi Star: Exploring the Exciting and Forbidden Worlds of the Benzophenone Photophore | Chemical Reviews The Life of Pi Star: Exploring the Exciting and Forbidden Worlds of the Benzophenone Photophore | Chemical Reviews](https://pubs.acs.org/cms/10.1021/acs.chemrev.6b00342/asset/images/medium/cr-2016-00342j_0226.gif)
The Life of Pi Star: Exploring the Exciting and Forbidden Worlds of the Benzophenone Photophore | Chemical Reviews
Fraser | Metavivorship and Narrative Repair in Teva Harrison's In-Between Days (2016) | Graphic Medicine Review
![Adjuvant Imatinib for High-Risk GI Stromal Tumor: Analysis of a Randomized Trial | Journal of Clinical Oncology Adjuvant Imatinib for High-Risk GI Stromal Tumor: Analysis of a Randomized Trial | Journal of Clinical Oncology](https://ascopubs.org/cms/10.1200/JCO.2015.62.9170/asset/images/jco629170t1.jpeg)